schizophrenia and use of revascularization procedures after acute myocardial infarction

1
Quality of Care and Outcomes Assessment E1898 JACC March 27, 2012 Volume 59, Issue 13 SCHIZOPHRENIA AND USE OF REVASCULARIZATION PROCEDURES AFTER ACUTE MYOCARDIAL INFARCTION ACC Moderated Poster Contributions McCormick Place South, Hall A Monday, March 26, 2012, 11:00 a.m.-Noon Session Title: Predictors, Correlations, and Outcomes Abstract Category: 31. Quality of Care and Outcomes Assessment Presentation Number: 1257-327 Authors: Karthik Murugiah, Gagan Kumar, Abhishek Deshmukh, Rajesh Sachdeva, Jawahar Mehta, Medical College of Wisconsin, Wauwatosa, WI, USA, University of Arkansas for Medical Sciences, Division of Cardiovascular Medicine, Little Rock, AR, USA Background: A growing literature has used differential rates of clinical outcomes and cardiovascular procedures as an indicator of potential inequalities in the health care system especially in vulnerable groups. Patients with Schizophrenia pose unique challenges due to affect, cognition, and socio-demographic factors. This study examines the outcomes of Acute Myocardial Infarction (AMI) in patients with Schizophrenia. Methods: Using Nationwide Inpatient Sample (NIS) 2000-08, patients >18 years with a primary discharge diagnosis of AMI and any diagnosis of Schizophrenia were identified through appropriate validated ICD-9-CM codes. Outcomes were in-hospital mortality, length of stay (LOS) and receipt of revascularization procedures. Results: Of 1,196,698 discharges with AMI 4,648 had diagnosed Schizophrenia. Patients with Schizophrenia presenting with AMI compared with remainder of the sample were younger (63.3±14 vs. 67.6±14 years), less likely male (53% vs. 59.8%), more likely diabetic (36.1% vs. 29.7%) and had higher charlson score (2.1±1.3 vs. 1.9±1.3) (all p<0.001). Patients with Schizophrenia had higher mortality (7.9 % vs. 6.2%), longer LOS (6.8 vs 5.3 days) and lower rates of percutaneous coronary intervention (PCI) (21.2% vs. 34.1%) and coronary artery bypass grafting (CABG) (5.5% vs. 8.3%) (all p<0.001). On multivariate analysis, Schizophrenia independently predicted increased mortality [Odds ratio (OR) 1.47, p<0.001] and patients with Schizophrenia were more likely to be medically managed (OR 2.11, p<0.001). There was no difference in the adjusted mortality between patients with and without Schizophrenia who underwent thrombolysis (p=0.35), PCI (p=0.95) or CABG (p=0.11). Conclusion: Using nationally representative data, this study shows that the in-hospital mortality and LOS of AMI in patients with Schizophrenia is higher and they are less likely to receive revascularization procedures. The outcome when they do receive coronary interventions is similar to the general population. Further research is needed to understand the degree to which patient and provider factors contribute to this disparity and its implications for quality and long-term outcomes of care.

Upload: jawahar

Post on 01-Jan-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: SCHIZOPHRENIA AND USE OF REVASCULARIZATION PROCEDURES AFTER ACUTE MYOCARDIAL INFARCTION

Quality of Care and Outcomes Assessment

E1898

JACC March 27, 2012

Volume 59, Issue 13

SCHIZOPHRENIA AND USE OF REVASCULARIZATION PROCEDURES AFTER ACUTE MYOCARDIAL

INFARCTION

ACC Moderated Poster ContributionsMcCormick Place South, Hall A

Monday, March 26, 2012, 11:00 a.m.-Noon

Session Title: Predictors, Correlations, and OutcomesAbstract Category: 31. Quality of Care and Outcomes Assessment

Presentation Number: 1257-327

Authors: Karthik Murugiah, Gagan Kumar, Abhishek Deshmukh, Rajesh Sachdeva, Jawahar Mehta, Medical College of Wisconsin, Wauwatosa, WI, USA, University of Arkansas for Medical Sciences, Division of Cardiovascular Medicine, Little Rock, AR, USA

Background: A growing literature has used differential rates of clinical outcomes and cardiovascular procedures as an indicator of potential

inequalities in the health care system especially in vulnerable groups. Patients with Schizophrenia pose unique challenges due to affect, cognition,

and socio-demographic factors. This study examines the outcomes of Acute Myocardial Infarction (AMI) in patients with Schizophrenia.

Methods: Using Nationwide Inpatient Sample (NIS) 2000-08, patients >18 years with a primary discharge diagnosis of AMI and any diagnosis of

Schizophrenia were identified through appropriate validated ICD-9-CM codes. Outcomes were in-hospital mortality, length of stay (LOS) and receipt

of revascularization procedures.

Results: Of 1,196,698 discharges with AMI 4,648 had diagnosed Schizophrenia. Patients with Schizophrenia presenting with AMI compared with

remainder of the sample were younger (63.3±14 vs. 67.6±14 years), less likely male (53% vs. 59.8%), more likely diabetic (36.1% vs. 29.7%) and

had higher charlson score (2.1±1.3 vs. 1.9±1.3) (all p<0.001). Patients with Schizophrenia had higher mortality (7.9 % vs. 6.2%), longer LOS (6.8 vs

5.3 days) and lower rates of percutaneous coronary intervention (PCI) (21.2% vs. 34.1%) and coronary artery bypass grafting (CABG) (5.5% vs. 8.3%)

(all p<0.001). On multivariate analysis, Schizophrenia independently predicted increased mortality [Odds ratio (OR) 1.47, p<0.001] and patients

with Schizophrenia were more likely to be medically managed (OR 2.11, p<0.001). There was no difference in the adjusted mortality between

patients with and without Schizophrenia who underwent thrombolysis (p=0.35), PCI (p=0.95) or CABG (p=0.11).

Conclusion: Using nationally representative data, this study shows that the in-hospital mortality and LOS of AMI in patients with Schizophrenia

is higher and they are less likely to receive revascularization procedures. The outcome when they do receive coronary interventions is similar to the

general population. Further research is needed to understand the degree to which patient and provider factors contribute to this disparity and its

implications for quality and long-term outcomes of care.